A Phase II, Open-Label Study of Ispinesib in Subjects With Locally Advanced or Metastatic Platinum-Refractory or Platinum-Relapsed Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2013
At a glance
- Drugs Ispinesib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Oct 2008 Checked against ClinicalTrails.gov record - last updated 9 Oct 2008.
- 22 Aug 2005 New trial record.